Constella: new treatment for constipation-predominant IBS

Chronic Constipation and Constipation-Predominant IBS: Separate and Distinct Disorders or a Spectrum of Disease?

Rome III diagnostic criteria separate patients with idiopathic chronic constipation into mutually exclusive categories of constipation-predominant irritable bowel syndrome (IBS-C) or functional constipation (FC). However, several experts think that these conditions are not different disorders, but parts of a continuum. To shed light on this issue, we examined studies that compared IBS-C with FC...

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom

BACKGROUND Several studies have examined the effect of irritable bowel syndrome (IBS) on health outcomes in Western Europe, but less research has focused on the constipation subtype (IBS-C). The current study addresses this gap by comparing patients with IBS-C and matched controls for health status, work productivity, and resource utilization. METHODS Data were obtained from the 2010 5EU Nati...

Challenges and New Treatment in Childhood Constipation

Chronic Constipation is a debilitating condition that is often associated with different abdominal problem. It can cause distress for the child and family and can result in emotional disturbance and family problem. Based on the current algorhytm, the treatment of chronic constipation consists of 4 important phases, 1: education, 2: disimpaction, 3: prevention of re-accumulation of feces and 4: ...

Impact of Chronic Constipation and Ibs*

The clinical and economic implications of chronic constipation (CC) and irritable bowel syndrome (IBS) and their negative impact on quality of life are considerable. Both of these functional gastrointestinal disorders produce frequent and bothersome symptoms of varying severity and account for limitations in performing daily activities, higher healthcare costs, increased utilization of medical ...

IBS-C irritable bowel syndrome with constipation